CCM
NPSP

Catapult Capital Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Catapult Capital Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-128,200
Closed -$1.94M – 345
2013
Q2 		$1.94M Buy
+128,200
New +$1.78M 0.81% 36

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Catapult Capital Management's NPSP Position: Q3 2013 in Review

Catapult Capital Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2013, closing a stake of 128,200 shares — an estimated $1.94M sold.

Catapult Capital Management first reported a position in NPSP in Q2 2013 and held it in 1 quarter. The position peaked at $1.94M in Q2 2013. 182 funds tracked by Wall St. Rank hold NPSP as of Q3 2013.

  • Catapult Capital Management reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Catapult Capital Management sold 128,200 NPS PHARMACEUTICALS INC shares in Q3 2013, an estimated $1.94M.
  • Catapult Capital Management first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Catapult Capital Management's NPS PHARMACEUTICALS INC position peaked at $1.94M in Q2 2013.
  • 182 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2013.

Based on Catapult Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.